Puma biotechnology investor presentation holnzuc

Puma biotechnology investor presentation

16.02.2021

Wedo48956

Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of Data source: Company presentation. Puma Biotechnology expects to explore additional expansions in HER2-positive breast cancer and HER2-mutated solid tumor cancers, but earning marketing approval Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its Chief Executive Officer and President, Alan H. Auerbach, will be presenting at the 38 th Annual J.P. Morgan On Jan. 13, 2020, Puma Biotechnology released the slides that CEO Alan Auerbach will present at the J.P. Morgan Healthcare Conf. on Jan. 15.

5 Feb 2020 Investor Relations · Contact · Careers · Advertise · Nasdaq MarketSIte · Trust Center · Privacy · Cookies · Legal

Puma Biotechnology Releases Slides To Be Presented At The J.P. Morgan Healthcare Bullish Puma Investor Talks Neratinb FDA Panel Win, Next Steps and Get breaking news and analysis on Puma Biotechnology, Inc. (PBYI) stock, price quote and chart, trading and investing tools. Puma Biotechnology, Inc. 2019 Q4 - Results - Earnings Call Presentation · SA Transcripts•Fri, Feb. 21. Puma Bio 5 Feb 2020 Investor Relations · Contact · Careers · Advertise · Nasdaq MarketSIte · Trust Center · Privacy · Cookies · Legal

5 Feb 2020 Investor Relations · Contact · Careers · Advertise · Nasdaq MarketSIte · Trust Center · Privacy · Cookies · Legal

Download our Investor Presentation and the Presentation for the Capital Markets Day 2018

Download our Investor Presentation and the Presentation for the Capital Markets Day 2018 Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of Find PUMA's Annual Report, Investor Presentations, information about upcoming financial events and have a look at the PUMA share. Find our Investor Presentations, information about upcoming financial events and have a look at the PUMA share Investor Relations. Overview. Share. Financial News. Financial Reports. Investor Presentations

At Puma Biotechnology, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of Find PUMA's Annual Report, Investor Presentations, information about upcoming financial events and have a look at the PUMA share. Find our Investor Presentations, information about upcoming financial events and have a look at the PUMA share Investor Relations. Overview. Share. Financial News. Financial Reports. Investor Presentations Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of Data source: Company presentation. Puma Biotechnology expects to explore additional expansions in HER2-positive breast cancer and HER2-mutated solid tumor cancers, but earning marketing approval Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of